Page last updated: 2024-10-29

iohexol and Nephrogenic Systemic Fibrosis

iohexol has been researched along with Nephrogenic Systemic Fibrosis in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pietsch, H1
Jost, G1
Frenzel, T1
Raschke, M1
Walter, J1
Schirmer, H1
Hütter, J1
Sieber, MA1
Kim, IY1
Lee, SB1
Lee, DW1
Song, SH1
Seong, EY1
Kwak, IS1

Other Studies

2 other studies available for iohexol and Nephrogenic Systemic Fibrosis

ArticleYear
Efficacy and safety of lanthanoids as X-ray contrast agents.
    European journal of radiology, 2011, Volume: 80, Issue:2

    Topics: Animals; Biopsy; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Contrast Media; Cyto

2011
Long-term effect of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease patients.
    Clinical and experimental nephrology, 2012, Volume: 16, Issue:5

    Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Iohexol; Kidney; Kidney Failure, C

2012